INDP CIK: 1857044

Indaptus Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.3
FY22:
−13.1
FY23:
−13.4
FY24:
−12.3
FY25:
−14.8
Change from FY21 to FY23
millions USD
FY21:
0.45
FY22:
−16.4
FY23:
17.1
FY24:
–
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
48.3
FY22:
–
FY23:
–
FY24:
4.75
FY25:
17.5
(positive)
millions USD
FY21:
−11.3
FY22:
–
FY23:
–
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR